Efficacy of Human Placental Graft in Diabetic Foot Ulcers (NCT03708029) | Clinical Trial Compass
TerminatedNot Applicable
Efficacy of Human Placental Graft in Diabetic Foot Ulcers
Stopped: Low enrollment.
United States9 participantsStarted 2018-11-13
Plain-language summary
To determine the efficacy of full-thickness placental allograft in chronic wound healing
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male and female patients
* 18-80 years old
* Diagnosis of Type 1 or 2 Diabetes Mellitus
* Foot ulcers \>1cm2 and \<25cm2 for 4 weeks or more prior to enrollment
* Able to give consent to participate
* Compliance with all aspects of protocol and follow-up
Exclusion Criteria:
* Male and female patients younger than 18 years old
* Male or female patients older than 80 years old
* Smoking, and any additional health risk factors contraindicated with Revita use
* Involvement in any other ongoing studies